Literature DB >> 17584128

Design, synthesis and biological evaluation of ligands selective for the melanocortin-3 receptor.

Victor J Hruby1, Minying Cai, James P Cain, Alexander V Mayorov, Matthew M Dedek, Devendra Trivedi.   

Abstract

The processed products of the proopiomelanocortin gene (ACTH, alpha-MSH, beta-MSH, gamma-MSH, etc.) interact with five melanocortin receptors, the MC1R, MC2R, MC3R, MC4R, and MC5R to modulate and control many important biological functions crucial for good health both peripherally (as hormones) and centrally (as neurotransmitters). Pivotal biological functions include pigmentation, adrenal function, response to stress, fear/flight, energy homeostasis, feeding behavior, sexual function and motivation, pain, immune response, and many others, and are believed to be involved in many disease states including pigmentary disorders, adrenal disorders, obesity, anorexia, prolonged and neuropathic pain, inflammatory response, etc. The melanocortin-3 receptor (MC3R) is found primarily in the brain and spinal cord and also in the periphery, and its biological functions are still not well understood. Here we review some of the biological functions attributed to the MC3R, and then examine in more detail efforts to design and synthesize ligands that are potent and selective for the MC3R, which might help resolve the many questions still remaining about its function. Though some progress has been made, there is still much to be done in this critical area.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17584128      PMCID: PMC2274922          DOI: 10.2174/156802607780906645

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  95 in total

1.  Design and syntheses of melanocortin subtype-4 receptor agonists: evolution of the pyridazinone archetype.

Authors:  Feroze Ujjainwalla; Daniel Warner; Thomas F Walsh; Matthew J Wyvratt; Changyou Zhou; Lihu Yang; Rubana N Kalyani; Tanya MacNeil; Lex H T Van der Ploeg; Charles I Rosenblum; Rui Tang; Aurawan Vongs; David H Weinberg; Mark T Goulet
Journal:  Bioorg Med Chem Lett       Date:  2003-12-15       Impact factor: 2.823

2.  New substituted piperazines as ligands for melanocortin receptors. Correlation to the X-ray structure of "THIQ".

Authors:  Felikss Mutulis; Sviatlana Yahorava; Ilze Mutule; Aleh Yahorau; Edvards Liepinsh; Sergei Kopantshuk; Santa Veiksina; Kaspars Tars; Sergey Belyakov; Anatoly Mishnev; Ago Rinken; Jarl E S Wikberg
Journal:  J Med Chem       Date:  2004-08-26       Impact factor: 7.446

3.  MC-3 receptor and the inflammatory mechanisms activated in acute myocardial infarct.

Authors:  Stephen J Getting; Clara Di Filippo; Helen C Christian; Connie W Lam; Francesco Rossi; Michele D'Amico; Mauro Perretti
Journal:  J Leukoc Biol       Date:  2004-07-26       Impact factor: 4.962

4.  Biological and conformational study of beta-substituted prolines in MT-II template: steric effects leading to human MC5 receptor selectivity.

Authors:  M Cai; C Cai; A V Mayorov; C Xiong; C M Cabello; V A Soloshonok; J R Swift; D Trivedi; V J Hruby
Journal:  J Pept Res       Date:  2004-02

5.  Synthesis and structure-activity relationships of novel arylpiperazines as potent and selective agonists of the melanocortin subtype-4 receptor.

Authors:  Timothy I Richardson; Paul L Ornstein; Karin Briner; Matthew J Fisher; Ryan T Backer; C Kelly Biggers; Michael P Clay; Paul J Emmerson; Larry W Hertel; Hansen M Hsiung; Saba Husain; Steven D Kahl; Jonathan A Lee; Terry D Lindstrom; Michael J Martinelli; John P Mayer; Jeffery T Mullaney; Thomas P O'Brien; Joseph M Pawlak; Kevin D Revell; Jikesh Shah; John M Zgombick; R Jason Herr; Alex Melekhov; Peter B Sampson; Chi-Hsin R King
Journal:  J Med Chem       Date:  2004-01-29       Impact factor: 7.446

6.  Solution structures of cyclic melanocortin agonists and antagonists by NMR.

Authors:  Jinfa Ying; Katalin E Kövér; Xuyuan Gu; Guoxia Han; Dev B Trivedi; Malcolm J Kavarana; Victor J Hruby
Journal:  Biopolymers       Date:  2003       Impact factor: 2.505

7.  Real time differentiation of G-protein coupled receptor (GPCR) agonist and antagonist by two photon fluorescence laser microscopy.

Authors:  Minying Cai; Magda Stankova; Stephanie J K Pond; Alexander V Mayorov; Joseph W Perry; Henry I Yamamura; Dev Trivedi; Victor J Hruby
Journal:  J Am Chem Soc       Date:  2004-06-16       Impact factor: 15.419

Review 8.  The central melanocortin system and the integration of short- and long-term regulators of energy homeostasis.

Authors:  Kate L J Ellacott; Roger D Cone
Journal:  Recent Prog Horm Res       Date:  2004

9.  Identification of 2-[2-[2-(5-bromo-2- methoxyphenyl)-ethyl]-3-fluorophenyl]-4,5-dihydro-1H-imidazole (ML00253764), a small molecule melanocortin 4 receptor antagonist that effectively reduces tumor-induced weight loss in a mouse model.

Authors:  Tricia J Vos; Andrei Caracoti; Jennifer L Che; Mingshi Dai; Cheryl A Farrer; Nancy E Forsyth; Stacey V Drabic; Robert A Horlick; Diana Lamppu; David L Yowe; Suresh Balani; Ping Li; Hang Zeng; Ingrid B J K Joseph; Luis E Rodriguez; Martin P Maguire; Michael A Patane; Christopher F Claiborne
Journal:  J Med Chem       Date:  2004-03-25       Impact factor: 7.446

10.  Functional characterization of melanocortin-3 receptor variants identify a loss-of-function mutation involving an amino acid critical for G protein-coupled receptor activation.

Authors:  Ya-Xiong Tao; Deborah L Segaloff
Journal:  J Clin Endocrinol Metab       Date:  2004-08       Impact factor: 5.958

View more
  15 in total

1.  Melanocortin-4 receptor gene polymorphism and the level of physical activity in men (HALS Study).

Authors:  Paweł Jóźków; Małgorzata Słowińska-Lisowska; Łukasz Łaczmański; Dorota Jakubiec; Marek Mędraś
Journal:  Endocrine       Date:  2010-11-03       Impact factor: 3.633

Review 2.  Melanotropins as drugs for the treatment of obesity and other feeding disorders: potential and problems.

Authors:  Minying Cai; Joel Nyberg; Victor J Hruby
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

3.  Association analysis of melanocortin 3 receptor polymorphisms with the risk of pulmonary tuberculosis.

Authors:  Byung Lae Park; Lyoung Hyo Kim; Suhg Namgoong; Ji On Kim; Jason Yongha Kim; Hun Soo Chang; Jong Sook Park; An Soo Jang; Sung Woo Park; Do Jin Kim; Ki Up Kim; Yang Gee Kim; Soo-Taek Uh; Ki Hyun Seo; Young Hoon Kim; Choon Sik Park; Hyoung Doo Shin
Journal:  Lung       Date:  2014-07-27       Impact factor: 2.584

Review 4.  Design of peptide and peptidomimetic ligands with novel pharmacological activity profiles.

Authors:  Victor J Hruby; Minying Cai
Journal:  Annu Rev Pharmacol Toxicol       Date:  2013       Impact factor: 13.820

5.  Cyclic lactam hybrid α-MSH/Agouti-related protein (AGRP) analogues with nanomolar range binding affinities at the human melanocortin receptors.

Authors:  Alexander V Mayorov; Minying Cai; Erin S Palmer; Dustin K Tanaka; James P Cain; Matthew M Dedek; Bahar Tan; Dev Trivedi; Victor J Hruby
Journal:  Bioorg Med Chem Lett       Date:  2011-03-13       Impact factor: 2.823

6.  Solid-phase peptide head-to-side chain cyclodimerization: discovery of C(2)-symmetric cyclic lactam hybrid α-melanocyte-stimulating hormone (MSH)/agouti-signaling protein (ASIP) analogues with potent activities at the human melanocortin receptors.

Authors:  Alexander V Mayorov; Minying Cai; Erin S Palmer; Zhihua Liu; James P Cain; Josef Vagner; Dev Trivedi; Victor J Hruby
Journal:  Peptides       Date:  2010-08-03       Impact factor: 3.750

Review 7.  Novel approaches to the design of bioavailable melanotropins.

Authors:  Yang Zhou; Minying Cai
Journal:  Expert Opin Drug Discov       Date:  2017-07-12       Impact factor: 6.098

Review 8.  Cardiovascular effects of melanocortins.

Authors:  Michael H Humphreys; Xi-Ping Ni; David Pearce
Journal:  Eur J Pharmacol       Date:  2011-01-01       Impact factor: 4.432

9.  Protein-Protein Interactions as New Targets for Ion Channel Drug Discovery.

Authors:  Svetla Stoilova-McPhie; Syed Ali; Fernanda Laezza
Journal:  Austin J Pharmacol Ther       Date:  2013-12-31

10.  Development and in vivo quantitative magnetic resonance imaging of polymer micelles targeted to the melanocortin 1 receptor.

Authors:  Natalie M Barkey; Christian Preihs; Heather H Cornnell; Gary Martinez; Adam Carie; Josef Vagner; Liping Xu; Mark C Lloyd; Vincent M Lynch; Victor J Hruby; Jonathan L Sessler; Kevin N Sill; Robert J Gillies; David L Morse
Journal:  J Med Chem       Date:  2013-08-09       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.